Objectives: ESBL genes in Escherichia coli are mainly plasmid encoded, although recent studies have also shown chromosomal integration, e.g. in clinical E. coli isolates of ST38. As ESBL-producing E. coli are also found in nonclinical settings, we were interested in determining whether chromosomally integrated ESBL genes occur in ST38 isolates from non-clinical habitats, e.g. wildlife.
Introduction
Gram-negative pathogens such as Escherichia coli acquire ESBLencoding genes such as bla CTX-M mostly via horizontal gene transfer of resistance plasmids. The presumed origin of these genes is the chromosome of Gram-negative soil bacteria such as different Kluyvera species, in which the bla CTX-M progenitor genes have moved to transferable plasmids. 1 In addition to the plasmiddriven spread of antimicrobial resistance (AMR), the transmission of ESBL-producing E. coli lineages and clones is of particular importance for their global success.
2 ESBL-producing E. coli have primarily been found in clinical settings, but more recently also in non-clinical settings, demonstrating their successful hostindependent spread in humans, livestock, companion animals and wildlife. 3, 4 In particular, avian wildlife, including birds of prey and waterfowl, 5, 6 is known to harbour E. coli that produce plasmidencoded ESBL enzymes, which has suggested environmental pollution with AMR determinants. 3, 4 A novel phenomenon is the chromosomal integration of usually plasmid-encoded ESBL genes in E. coli, 7-10 exemplified by their occasional detection in clinically relevant E. coli isolates of ST38, ST410, ST131 and ST648. 11 More recently, the successful spread of a clonal group of E. coli of ST38 carrying a chromosomally encoded carbapenemase gene (bla OXA-48 ) has been reported from the UK. 7 While the presence of chromosomally encoded ESBL or carbapenemase genes in E. coli in clinical settings has been established, information on the presence of such genes in wildlife or the environment is greatly lacking. In this study we investigated whether the clinical phenomenon of chromosomally encoded ESBL and carbapenemase genes occurs in ST38 E. coli isolated from wild birds sampled in a remote area of the Mongolian Gobi desert. This work is aimed at contributing to the understanding of chromosomally encoded broad-spectrum cephalosporinases.
Materials and methods
The four ESBL-producing E. coli ST38 isolates originated from cloacal swabs taken from 63 wild birds [vultures (n " 34), falcons (n " 17), kites (n " 8), eagles (n " 2), crane (n " 1), eagle owl (n " 1)], from six different sampling sites in the South Gobi desert within a radius of 300 km around 43 53 0 56.4 00 N/107 40 0 47.3 00 E during the Mongolian-German Biological Expedition in summer 2015 (detailed geographic origin: Table 1 ). Each animal was sampled once and cloacal swabs (MASTASWAB containing Amies medium with charcoal, Mast Diagnostica, Reinfeld, Germany) were shipped to our laboratory (Institute of Microbiology and Epizootics, Berlin, Germany). Preselection for cefotaxime-resistant E. coli was carried out by streaking the swabs on CHROMagar TM orientation plates (4 mg/L cefotaxime; Mast Diagnostica, Reinfeld, Germany). The species of coliform-appearing isolates was determined using the automated VITEKV R 2 system (BioMérieux, Germany), which was also used for phenotypic resistance determination (card GN38). ESBL-producers were confirmed using the phenotypic confirmatory test for ESBL production, according to CLSI guideline M31-A3
12 to exclude AmpC-producing isolates. Confirmed ESBL-producing E. coli isolates were whole-genome sequenced using Illumina MiSeq 300 bp paired-end sequencing with an obtained coverage .50%. After quality control using the NGS tool kit 13 (70% of bases with a phred score .20), high-quality filtered reads were used for de novo assembly into contiguous sequences (contigs) using the CLC Genomics workbench v. 9.0 and into nodes using SPAdes.
14 Assembled draft genomes of the isolates were annotated using the rapid annotation server RAST. 15 WGS data were used for genotypic characterization including the determination of the MLST ST (MLSTFinder 16 ), resistance genes (ResFinder 2.1, 17 threshold: 90% ID, 60% minimum length) and plasmids (PlasmidFinder 1.3, 18 threshold: 95% ID). BLAST analysis of the assembled contigs/nodes and evaluation of the flanking regions was performed using features of NCBI-BLAST and Geneious v. 7.1.2. 19 Chromosomal insertion sites of the bla CTX-M genes were verified with 500-800 bp conventional PCR and subsequent Sanger sequencing using a commercial service (LGC Genomics Berlin, Germany). Primers were designed using the primer generation function of Geneious, based on contigs of the WGS data of the isolates.
The number of SNPs in the core genome between the isolates was calculated using Harvest suite 1.0 (parsnp) 20 and MEGA 6.0 (http://www.mega software.net/). WGS data from the ST38 UK outbreak were obtained from the European Nucleotide Archive (http://www.ebi.ac.uk/ena/data/view/ ERP014272). Phenotypic plasmid profile analysis was performed as described previously 21 and repeated three times.
Results and discussion
Fourteen percent of wild birds (9/63) carried ESBL-producing E. coli with six different STs and a dominance of ST38 (4/9). Carbapenemase-producing E. coli were not detected. Isolates of ST38 originated from four individual birds, of two different species (Monk Vulture and Black Kite) and four different sampling locations (Table 1) . Details on the other five ESBL-producing E. coli, including ST, avian host species and sampling location, can be found in the Supplementary data (Table S1 , available at JAC Online).
As the birds were sampled at distant sampling points, a direct clonal link seemed rather unlikely, which was supported by the WGS results: parsnp detected 4900-9300 SNPs between the different ST38 isolates. When considering the very low number of SNPs that were detected for an ESBL-producing E. coli clone from clinical and non-clinical settings in Germany, 21 our results suggest a Figure S1 ). Large plasmids, however, were absent in the other three ST38 isolates (IMT37350, IMT37356, IMT37362). This observation suggested a possible chromosomal location for the resistance against thirdgeneration cephalosporins. This was further supported by the subsequent WGS analysis of both assembled genomes (CLC and SPAdes) for the three ST38 isolates: (i) the bla CTX-M genes were mostly detected on very large contigs/nodes; (ii) the BLAST analysis revealed mostly chromosomal hits for the CTX-M-carrying contigs/nodes; and (iii) no typical ESBL-associated Inc types were identified. Mobile elements (IMT37350: ISEcp1/IS903B, IMT37356: ISEcp1/TN3, IMT37362: ISEcp1) and phage-associated genes that flanked the CTX-M-encoding genes reinforced our hypothesis. As shown in Figure 1 , we found three different insertion regions for three different bla CTX-M genes (bla CTX-M-14 , bla CTX-M-15 , bla CTX-M-24 ) in the three ST38 isolates. Differing bla CTX-M types and insertion locations as well as the high number of SNPs between the ST38 isolates clearly indicate independent chromosomal insertion events of the bla CTX-M genes. PCR and Sanger sequencing of the bla CTX-M integration regions confirmed the reliability of the WGS data as we obtained identical sequences of approximately 5000 bp around the bla CTX-M insertion site that reached into genes of the chromosomal content for IMT37350 and IMT37362 or into a phage region for IMT37356.
Interestingly, when comparing the WGS data of the ST38 wild bird isolates from this study with those of 23 human clinical isolates of ST38 from a recent clonal outbreak in the UK, 7 we observed that IMT37350 harboured only 55-225 SNPs when compared with 8 SNPs from the clinical outbreak isolates (original strain designation ST38_1, ST38_13, ST38_15, ST38_16, ST38_18, ST38_20, ST38_21, ST38_22). Despite the carriage of a chromosomally encoded carbapenemase gene (bla OXA-48 ) these clinical strains were more closely related to a Mongolian ST38 wild bird isolate than to some of those from the actual outbreak (.4000 SNPs).
In conclusion, our data show that the current clinical phenomenon of chromosomal inclusion of ESBL genes is mirrored in wildlife samples. The reason why ST38 appears to be associated with the chromosomal carriage of ESBL and carbapenemase genes remains unclear. However, our study indicates that the chromosomal insertion of different bla CTX-M types in different locations is not a rare or singular event. The stability and duration of the transposition of bla CTX-M into chromosomal locations is largely unknown, and the resulting consequences should be further investigated. A more stable retention of the chromosomally encoded resistance genes compared to plasmids in the absence of AMR selection pressures has previously been suggested. 9 The high proportion of chromosomally encoded bla CTX-M detected in this avian population points toward an evolutionary process that likely promotes the maintenance of resistance genes in the population by translocation to the bacterial chromosome independent from costly plasmid carriage, 8 although we have recently observed no fitness costs by carrying ESBL-plasmids in E. coli. 22 Possible reasons for this discrepancy could be costs that depend on the host strain or the existence of genetic mechanisms within ST38 strains that promote chromosomal resistance gene carriage. In addition to the chromosomal location of bla CTX-M genes the detected similarity between a Mongolian wildlife isolate and European clinical isolates underlines the global environmental dimension and zoonotic character of ESBL-producing E. coli.
